- Home
- IREN vs MIRM Comparison
IREN vs MIRM Comparison
Compare IREN & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IREN
- MIRM
- Stock Information
- Founded
- IREN 2018
- MIRM 2018
- Country
- IREN Australia
- MIRM United States
- Employees
- IREN N/A
- MIRM N/A
- Industry
- IREN EDP Services
- MIRM Biotechnology: Pharmaceutical Preparations
- Sector
- IREN Technology
- MIRM Health Care
- Exchange
- IREN Nasdaq
- MIRM Nasdaq
- Market Cap
- IREN 2.1B
- MIRM 1.9B
- IPO Year
- IREN 2021
- MIRM 2019
- Fundamental
- Price
- IREN $10.67
- MIRM $44.50
- Analyst Decision
- IREN Strong Buy
- MIRM Strong Buy
- Analyst Count
- IREN 11
- MIRM 13
- Target Price
- IREN $14.90
- MIRM $57.00
- AVG Volume (30 Days)
- IREN 19.2M
- MIRM 356.8K
- Earning Date
- IREN 11-26-2024
- MIRM 11-12-2024
- Dividend Yield
- IREN N/A
- MIRM N/A
- EPS Growth
- IREN N/A
- MIRM N/A
- EPS
- IREN N/A
- MIRM N/A
- Revenue
- IREN $188,758,000.00
- MIRM $307,028,000.00
- Revenue This Year
- IREN $148.59
- MIRM $73.07
- Revenue Next Year
- IREN $38.72
- MIRM $27.98
- P/E Ratio
- IREN N/A
- MIRM N/A
- Revenue Growth
- IREN 149.98
- MIRM 112.14
- 52 Week Low
- IREN $2.79
- MIRM $23.14
- 52 Week High
- IREN $15.75
- MIRM $48.89
- Technical
- Relative Strength Index (RSI)
- IREN 54.11
- MIRM 65.32
- Support Level
- IREN $10.53
- MIRM $41.09
- Resistance Level
- IREN $12.43
- MIRM $48.89
- Average True Range (ATR)
- IREN 0.99
- MIRM 2.16
- MACD
- IREN 0.02
- MIRM 0.57
- Stochastic Oscillator
- IREN 49.37
- MIRM 59.09
About IREN Iris Energy Limited
Iris Energy Ltd is a Bitcoin mining company. It builds, owns, and operates data centers and electrical infrastructure for the mining of Bitcoin powered by renewable energy. The company's mining operations generate revenue by earning Bitcoin through a combination of block rewards and transaction fees from the operation of its specialized computers called Application-specific Integrated Circuits and exchanging these Bitcoin for currencies such as USD or CAD on a daily basis.
About MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter "IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.